Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03099434 · ClinicalTrials.gov registry record · NA
Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media
A NA study of Kidney Diseases and Kidney Failure, sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 775
- Enrollment target
- 2
- Study locations
NCT03099434: Active NA study of Kidney Diseases and Kidney Failure, sponsored by Johns Hopkins University.
NCT03099434 is a NA study of Kidney Diseases and Kidney Failure that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 775 participants, below the 1,765-participant average among 38 other Kidney Diseases trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03099434, a NA study of Kidney Diseases and Kidney Failure, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 775 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot study will be a clinical trial to test the feasibility and effectiveness of an educational intervention and a mobile health intervention in adults with end stage renal disease (ESRD) who have not yet identified a potential live donor.
Primary Outcome
Live donor kidney transplantation within one year of enrollment into the study will be the primary outcome and will be collected/identified through electronic medical record system.
Conditions Studied
Interventions
- BEHAVIORAL Facebook App
- BEHAVIORAL Live Donor Champion + Facebook App
Study Locations (2)
Illinois
- Northwestern University - Evanston
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 775 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2026-12-07 |
| Phase | NA |
What the registry record for NCT03099434 still lists
NCT03099434 is an interventional study that assigns participants to a tested intervention. The registered 775 participants enrollment target is mid-sized for trials with a published cap, below the 1,765-participant average among 38 other Kidney Diseases trials with a reported enrollment target (56% lower).
The record links to 2 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which Facebook App is the first listed.
NCT03099434 reports a single indexed study location in Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT03099434 about?
NCT03099434 is a clinical study titled "Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media". This pilot study will be a clinical trial to test the feasibility and effectiveness of an educational intervention and a mobile health intervention in adults with end stage renal disease (ESRD) who have not yet identified a potential live donor.
What is the current status of trial NCT03099434?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 775 participants. The study started on 2017-04-01. Estimated completion is 2026-12-07.
What conditions does trial NCT03099434 study?
This clinical trial studies the following conditions: Kidney Diseases, Kidney Failure.
What interventions are being tested in trial NCT03099434?
The interventions under investigation include: Facebook App (BEHAVIORAL), Live Donor Champion + Facebook App (BEHAVIORAL).
Who is sponsoring clinical trial NCT03099434?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03099434 being conducted?
This trial has 2 study locations across Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03099434's enrollment target sits among peer trials
775 6th of 38 higher than 33 of 38 other Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03460769 · 775 participants
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
- NCT06145763 · 776 participants · NA
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
- NCT05642611 · 777 participants · Phase 3
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
- NCT06841679 · 778 participants · Phase 2
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI